---
title: "This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297053341.md"
description: "Top Wall Street analysts initiated coverage on several stocks with bullish outlooks. Needham's Serge Belanger rated Evommune (EVMN) as Buy with a $28 target. Daiwa Capital's Bintuo Ni rated ACM Research (ACMR) as Buy with a $136 target. Wolfe Research's Rudy Li rated Harmony Biosciences (HRMY) as Outperform with a $60 target. RBC Capital's Matthew Hedberg rated Atlassian (TEAM) and JFrog (FROG) as Outperform with targets of $215 and $118, respectively."
datetime: "2026-08-26T13:15:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297053341.md)
  - [en](https://longbridge.com/en/news/297053341.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297053341.md)
generator: "portal-rs"
---

# This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Needham analyst Serge Belanger initiated coverage on **Evommune Inc** (NYSE:EVMN) with a Buy rating and announced a price target of $28. Evommune closed at $13.79 on Tuesday. See how other analysts view this stock.
-   Daiwa Capital analyst Bintuo Ni initiated coverage on **ACM Research Inc** (NASDAQ:ACMR) with a Buy rating and announced a price target of $136. ACM Research shares closed at $79.77 on Tuesday. See how other analysts view this stock.
-   Wolfe Research analyst Rudy Li initiated coverage on **Harmony Biosciences Holdings Inc** (NASDAQ:HRMY) with an Outperform rating and announced a price target of $60. Harmony Biosciences closed at $38.95 on Tuesday. See how other analysts view this stock.
-   RBC Capital analyst Matthew Hedberg initiated coverage on **Atlassian Corp** (NASDAQ:TEAM) with an Outperform rating and announced a price target of $215. Atlassian shares closed at $166.49 on Tuesday. See how other analysts view this stock.
-   RBC Capital analyst Matthew Hedberg initiated coverage on **JFrog Ltd** (NASDAQ:FROG) with an Outperform rating and announced a price target of $118. JFrog closed at $89.48 on Tuesday. See how other analysts view this stock.

Considering buying ACMR stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [EVMN.US](https://longbridge.com/en/quote/EVMN.US.md)
- [TEAM.US](https://longbridge.com/en/quote/TEAM.US.md)
- [FROG.US](https://longbridge.com/en/quote/FROG.US.md)
- [ACMR.US](https://longbridge.com/en/quote/ACMR.US.md)
- [HRMY.US](https://longbridge.com/en/quote/HRMY.US.md)
- [688082.CN](https://longbridge.com/en/quote/688082.CN.md)

## Related News & Research

- [RBC Capital Is Feeling Bullish on Atlassian Stock. Here's Why.](https://longbridge.com/en/news/297083165.md)
- [Atlassian Chief Accounting Officer Gene Liu sells 1,125 common shares for $196,875](https://longbridge.com/en/news/296545329.md)
- [Atlassian Chief Financial Officer Sold Shares Worth Over $1.5M](https://longbridge.com/en/news/296545652.md)
- [Did JFrog's (FROG) AI‑Security swampUP 2026 Agenda Just Reframe Its Investment Narrative?](https://longbridge.com/en/news/296664633.md)
- [JFrog to Host Investor and Financial Analyst Event at swampUP 2026 | FROG Stock News](https://longbridge.com/en/news/296825015.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**